The hair loss treatment that takes just 90 SECONDS - and it's FDA-cleared, drug-free, and $150 off today: 'Never seen new growth like this until now!'
Hair loss doesn't usually show up overnight. Sometimes it begins as more of a subtle widening of your part or a thinned out ponytail. The most common form, known as androgenic alopecia, affects millions of men and women all over the world.
If you're among them, you know it can have a real impact on self-confidence. The good news is that the Hairmax LaserBand 82 ComfortFlex is designed to provide a safe and drug-free solution that fits your life without messiness or invasiveness.
Hairmax LaserBand 82 ComfortFlex
Support healthy hair growth with an FDA-cleared device that uses medical-grade laser therapy to help revitalize thinning strands at the root.
It's drug-free, pain-free, and takes just 90 seconds per treatment, without the need for downtime and without the risk of side effects.
Designed for comfort and ease of use, it fits seamlessly into your routine and is suitable for both men and women. You may see results in as little as a few months with consistent use!
Enter SAVE150 at checkout through August 20, 2025, to save $150 on your order now.
Save $150 Shop
The device is both FDA-cleared and clinically proven to deliver powerful laser therapy right to your scalp. Impressively, it does this in as little as 90 seconds per session.
Now is a fitting time to get started, too! August is Hair Loss Awareness Month, and Hairmax is running a Buy More, Save More Sale with savings of up to $300 off sitewide. That includes the LaserBand 82, which is an impressive $150 off right now when you enter code SAVE150 at checkout through August 20, 2025.
It's a low-commitment solution that harnesses the power of 82 medical-grade lasers and a flexible band that fits comfortably on most heads. The LaserBand 82 is essentially a state-of-the-art headband with a true futuristic vibe.
As soon as you slip it on, it gently parts your hair with its soft-touch teeth, allowing the laser lights to penetrate directly to your hair follicles. This action stimulates hair growth over time, reversing thinning strands and encouraging healthier locks.
Consistency and speed are both the hallmarks that set the LaserBand 82 apart from the rest. Just three sessions per week is all that it takes, and for many users the difference is visible in only a matter of weeks.
In fact, it's proven to be so effective that it's clinically shown to have a 93 percent success rate. Used regularly, you can expect to see results within just three months!
One reviewer shared, 'I've been using this a little less than 90 days and started seeing new hair growth at around the 45-60 day timeframe. It's amazing! I have never seen new growth like this until now!'
'Using the LaserBand82 is the best way to get the benefits of the laser therapy in the shortest amount of time. Great results, my hair has thickened and it looks fuller,' raved another.
'I have hair growth all over my head with baby hair shoots,' said a third. 'My hairline has filled in some around the temple and sides. Hair is growing!'
Unlike other treatments that come with a whole slew of possible side effects or require you to commit to a prescription, Hairmax laser devices don't contain medication. It's a key reason why so many dermatologists recommend them as part of a manageable hair wellness routine.
No matter where you are on your hair growth journey, using the Hairmax LaserBand 82 ComfortFlex can help you regain lost strands and boost your confidence. Don't miss it while it's on sale for $150 off!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
16 minutes ago
- The Independent
Family issues warning as son dies after taking highly addictive over-the-counter supplement: ‘The government doesn't step in'
A family in Washington is warning about the dangers of kratom — a supplement that can be bought in some gas stations — after they say their son died from using the substance. On the day Jordan McKibban, 37, died in 2022, he reportedly mixed kratom with his lemonade, according to his mother, Pam Mauldin, who spoke to the New York Post. Kratom is marketed as an "all-natural" supplement that can help reduce pain, anxiety, and depression, among other ailments. For some individuals who are wary of typical pharmaceutical medicines — as McKibban reportedly was — kratom can be an attractive alternative. Mauldin found her son unconscious in his room after he drank the kratom-lemonade mixture. She attempted CPR, but could not revive him. 'I've lost my son. I've lost my grandchildren that I could have had, I've lost watching him walk down that aisle, watching him have a life that I get to watch with my other kids. I've lost enjoying these years with him,' she told the New York Post. After his death, an autopsy found that McKibban death was caused by mitragynine, which is found in ktraom. Kratom is made from a Southeast Asian plant and can act as a stimulant when taken in lower doses and a sedative when taken at higher doses. The substance can be bought from online retailers and in stores legally. The U.S. Food and Drug Administration notes that kratom hasn't been shown to be safe or effective at treating any medical conditions. The agency has described it as a "drug of concern." Despite its open availability, national poison control centers have documented 1,807 calls about kratom exposure between 2011 and 2017, and the calls are becoming more frequent, according to Dr Michael Greco, who spoke to the New York Post. He warned that kratom use can, in some people, cause them to experience agitation and "sometimes even psychosis." However, kratom deaths are rare. In McKibban's situation, he was told that he could not overdose on the substance, and that he would simply vomit if he took too much, according to his mother. She noted that her son's kratom bags had no instructions on them or dosage suggestions. 'There have been hundreds of people killed from this, and they don't pull it. The government doesn't step in,' she said. That may be changing. U.S. Secretary of Health and Human Services Robert F Kennedy Jr announced in late July that he plans to crack down on kratom. 'I became an addict because [heroin] was so available, but I had to go to the South Bronx or the Lower East Side. But now you can go to any gas station,' Kennedy told reporters on July 29 while discussing the substance. 'They're marketing them to children: They're gummy bears, they're bright colors, they're candy-flavored. This is really a sinister, sinister industry.' He was referring to a reportedly more addictive and possibly more dangerous offshoot of kratom called 7-hydroxymitragynine. Dr Robert Levy, an addiction and family doctor, told the New York Post that the substance can have similar effects to opioids. 'There's always been concern around kratom because if you take enough of it, kratom does act like an opioid, and people can become addicted to it and have withdrawal from it and overdose on it and ruin their lives on it, like anybody else that has a substance use disorder,' Levy said. He said the offshoot product that is "much more addicting and much more problematic" has infiltrated the market, and many consumers don't know the difference. The FDA recently recommended 7-hydroxymitragynine be classified as an illicit substance. '7-OH is an opioid that can be more potent than morphine,' FDA Commissioner Marty Makary, said in a press release. 'We need regulation and public education to prevent another wave of the opioid epidemic.' Levy recommended that parents talk to their children or loved ones about the substance and remind them that just because something is "all-natural" and plant-derived does not mean it's safe for consumption. "Arsenic is also from a plant," he noted. He advised that anyone with a family member struggling with substance abuse of any kind to seek out available resources and treatment options.
The Independent
16 minutes ago
- The Independent
What is glioma? Symptoms explained after death of young actress
Actor Kelley Mack has died at the age of 33 after being diagnosed with glioma of the central nervous system, a type of brain cancer. Her family announced the news, having previously set up a CaringBridge page to provide updates on her condition. Mack was known for her role as Addy in five episodes of The Walking Dead in 2019, and also appeared in 9-1-1, Chicago Med, and Spider-Man: Into the Spider-Verse. Glioma is the most common type of brain cancer in children and younger adults, originating in glial cells and categorized by cell type, growth potential, and aggressiveness. Symptoms can include headaches, vision problems, and seizures, with treatment options varying from surgery to chemotherapy and radiotherapy, depending on the tumour's grade and location.
The Independent
2 hours ago
- The Independent
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
